National Community Pharmacists Association

12/24/2025

Engaging Your Community: Cervical Cancer Awareness
📅 Jan. 7, 2026 | ⏰ 9-10 p.m. ET

Community Connected, a CPESN® initiative, supports pharmacies in delivering patient-centered services that reflect the needs of their communities. This session will outline what pharmacies should know about cervical cancer and how to implement clinical services that better support affected populations.

🔗 Register here:

12/24/2025

Happy holidays from all of us at NCPA! ❄️✨ Wishing you joy, rest, and a bright start to the new year.

12/22/2025

Hear from Marc Ost, one of our pharmacy member leaders from last month's NCPA Committee Forum, on the software you can consider to improve your medical billing in 2026. The right tools can streamline workflows, reduce errors, and strengthen your bottom line. 💡💻

12/21/2025

PTCE is offering a free hypertension CE webinar designed to help pharmacists optimize care with single-pill combination therapy.

Don’t miss expert insights from Bruce A. Warden, PharmD, BCPS, CLS, FNLA, FASPC, tomorrow at 1 and 8 p.m. ET.

Attend and earn 1.0 live CE credit:

This webinar will equip practicing pharmacists to identify patients with hypertension who might benefit from triple combination therapy initiation, focusing on those with specific comorbidities and elevated risk.

12/20/2025

👋 Meet Your Team: Kaite Krell, director of congressional affairs

Kaite grew up in rural Wyoming, earned her MPH from George Washington University, and spent nearly eight years working for her home-state senators before joining NCPA in 2023. Both her passion for health care policy and her commitment to community pharmacy run deep.

She serves as one of NCPA’s key voices on Capitol Hill, advising on legislation, meeting with lawmakers, and driving grassroots action.

🧵 In her downtime? Books, sewing, and cosplay projects.

📖 Read more about Kaite in this month’s America’s Pharmacist®: https://ncpa.org/americas-pharmacist

12/20/2025

🎙️ New podcast episode: Inside the Newly Improved Community Pharmacy Fellowship

Host John Beckner sits down with leaders from NCPA and CPESN® to break down what’s new in the Community Pharmacy Fellowship. Learn how the program evolved, why medication synchronization is a key focus, and what you need to know before applications close on Jan. 31, 2026.

🎧 Stream now: https://ncpa.org/rxforumpodcast

12/19/2025

Calling all pharmacy students! 📣

This tip from Oluwateti Omilana during last month's NCPA Committee Forum highlights the many ways you can start building your professional life with NCPA — and set yourself up for success early in your career. ✨

12/19/2025

✨ It’s hard to believe was already two months ago!

Relive the energy, the learning, and the moments that brought our independent pharmacy community together. 🎥

Save the date for in Kansas City, Oct. 3-6!

12/17/2025

Get ready to level up your pharmacy in 2026. 💡

In this on-demand webinar, the IPC Pharmacy Services team shares practical strategies to boost revenue, streamline workflow, and expand clinical services — with steps you can take in the first 90 days.

Watch now:

Business Booster webinar on Demand Transform Your Pharmacy in 2026 with IPC Pharmacy Services Transform Your Pharmacy in 2026 with IPC Pharmacy Services Grow Your Pharmacy Revenues with Probiotics Grow Your Pharmacy Revenues with Probiotics October 15, 2025 Exploring Common Bonds: Community Pharmaci...

12/16/2025

👏 👏 👏 "If the American patient experience is to become better and more cost effective, we must rein in massive federal spending on deeply fraudulent and wasteful PBMs like CVS Caremark," wrote Sen. Marsha Blackburn to CVS Health CEO David Joyner, requesting that he respond to questions about "the company’s lengthy record of fraud and regulatory violations at taxpayers’ expense and the role the company has played in driving up health care costs."

12/16/2025

🎙️ ICYMI : Fair Pricing for Type 2 Diabetes Care

From the expo floor, hosts John Beckner and Ed Cohen sit down with Brian Connelly of TheracosBio to discuss Brenzavvy (bexagliflozin), an FDA-approved SGLT2 inhibitor for adults with Type 2 diabetes. They explore how TheracosBio’s PBM-free model supports fair, transparent pricing for both pharmacists and patients.

🎧 Stream now: https://ncpa.org/rxforumpodcast